EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effects of repeated doses of xylazine-ketamine and medetomidineketamine anesthesia on DNA damage in the liver and kidney

Tunahan Sancak

Acta Cirúrgica Brasileira · 2023 · 38

DOI: 10.1590/acb385723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Cirúrgica Brasileira, 2023. Verfasst von Tunahan Sancak. Beteiligte Einrichtung: Sivas Cumhuriyet University - Veterinary Faculty - Department of Surgery - Sivas - Turkey. Hauptthemen laut MEDLINE: Ketamine, Anesthesia, Anesthetics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study evaluated the DNA damage caused by repeated doses of xylazine-ketamine and medetomidine-ketamine anesthesia in the liver and kidneys.

Methods

In this study, 60 rats were used. The rats were divided into group 1 (xylazine-ketamine), and group 2 (medetomidine-ketamine), and these anesthetic combinations were administered to the rats at repeated doses with 30-min intervals. The effects of these anesthetic agents on the tumor necrosis factor-alpha gene for DNA damage were investigated.

Results

According to the gene expression results, it was observed that a single dose of xylazine-ketamine was 2.9-fold expressed, while first and second repeat doses did not show significant changes in expression levels. However, in the case of the third repetition, it was observed to be 3.8-fold overexpressed. In the case of medetomidine-ketamine administration, it was observed that a single-dose application resulted in a 1.04-fold expression, while the first and the third repeat doses showed a significant down expression. The samples from the second repeat dose administration group were found to have insignificant levels of expression.

Conclusions

This study can contribute to understanding the safe anesthetic combination in research and operations in which xylazine-ketamine and medetomidine-ketamine combinations are used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAnesthesiaAnestheticsAnimalsRatsXylazineMedetomidineLiverKidneyDNA Damage

Substanzen

KetamineXylazineMedetomidineAnesthetics

Autor:innen und Institutionen

  • Sivas Cumhuriyet University - Veterinary Faculty - Department of Surgery - Sivas - Turkey.

Zitieren

APA

Sancak, T. (2023). The effects of repeated doses of xylazine-ketamine and medetomidineketamine anesthesia on DNA damage in the liver and kidney. Acta Cirúrgica Brasileira, 38. https://doi.org/10.1590/acb385723

Vancouver

Sancak T. The effects of repeated doses of xylazine-ketamine and medetomidineketamine anesthesia on DNA damage in the liver and kidney. Acta Cirúrgica Brasileira. 2023;38. doi:10.1590/acb385723

BibTeX
@article{Sancak2023,
  author = {Sancak, Tunahan},
  title = {The effects of repeated doses of xylazine-ketamine and medetomidineketamine anesthesia on DNA damage in the liver and kidney},
  journal = {Acta Cirúrgica Brasileira},
  year = {2023},
  volume = {38},
  doi = {10.1590/acb385723}
}
Kostenlos starten →